Medicine Overview
Adult Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Hypertension (HTN) Age: Adult |
Dose: Tablet by mouth – 50 mg Frequency: once daily Note: May increase to 50 mg by mouth every 12 hours; may take up to four weeks for full therapeutic response; hyperkelemia may occur with doses greater than 100 mg/day |
|
Indication: Heart Failure Post MI Age: Adult |
Dose: Tablet by mouth – 25 mg Frequency: once daily Duration: within 4 weeks Note: May titrate to maximum of 50 mg once daily as tolerated; dose adjustments may be required based on potassium levels |
Child Dose
| Clinical Information | Administration Information |
|---|---|
|
Age: Pediatric |
Dose: Dose: Note: No approved pediatric dosage available |
Renal Dose
| Clinical Information | Administration Information |
|---|---|
|
Age: Male Condition: Renal Impairment |
Dose: Not mentioned Note: Contraindicated if Creatinine Clearance less than 50 mL/min or serum creatinine greater than 2 mg/dL |
|
Age: Female Condition: Renal Impairment |
Dose: Not mentioned Note: Contraindicated if Creatinine Clearance less than 50 mL/min or serum creatinine greater than 1.8 mg/dL |
Administration
- Take with or without food
- Take at same time each day
Side Effect
- Hyperkalemia (2-10%)
- Increased risk of hyperkalemia with presence of renal dysfunction
- Dizziness
- Fatigue/malaise
- Abdominal pain
- Diarrhea
- Albuminuria
- Hypercholesterolemia
- Hypertriglyceridemia
- Cough
- Abnormal vaginal bleeding
- Gynecomastia
- Mastodynia
Drug Interaction
Drug Interaction
| Drug Name | Risk Factors |
|---|---|
|
CYP3A4 Inhibitors (e.g. ketoconazole, voriconazole, itraconazole, fluconazole, clarithromycin, diltiazem saquinavir, verpamil, ritonavir)
|
May increase serum concentrations of Eplerenone
|
|
CYP3A4 inducers (e.g. rifampicin, carbamazepine, phenytoin, phenobarbital)
|
May decrease Eplerenone efficacy
|
Disease Interaction
Disease Interaction
| Disease Name | Risk Factors |
|---|---|
|
Serum Potassium >5 mEq/L at Initiation
|
Risk of dangerous hyperkalemia
|
|
CrCl ≤30 mL/min
|
Risk of kidney complications
|
Pregnancy
Pregnancy
Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Store below 30°C in a cool and dry place, protected from light and moisture. Keep out of children’s reach.
Data Sources
Clinical & regulatory information on this page is compiled from the following government sources:
DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.